Beneficent insiders purchase $35K of stock at $1.06 per share

Beneficient

On 9/15/26, CEO James Silk bought 9,434 shares, Peter Cangany 18,868, Derek Fletcher 4,717, all at $1.06/share.
Total proceeds to Beneficient from these unregistered sales are about $35,000 (33,019 shares).
Shares sold under Section 4(a)(2) and Regulation D to accredited investors for investment, not distribution.
Silk is CEO; Cangany and Fletcher are board members, with Fletcher also Chief Fiduciary Officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.